BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Long J, Liu XK, Kang ZP, Wang MX, Zhao HM, Huang JQ, Xiao QP, Liu DY, Zhong YB. Ginsenoside Rg1 ameliorated experimental colitis by regulating the balance of M1/M2 macrophage polarization and the homeostasis of intestinal flora. Eur J Pharmacol 2022;917:174742. [PMID: 34999087 DOI: 10.1016/j.ejphar.2022.174742] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Kang J, Zhou Y, Zhu C, Ren T, Zhang Y, Xiao L, Fang B. Ginsenoside Rg1 Mitigates Porcine Intestinal Tight Junction Disruptions Induced by LPS through the p38 MAPK/NLRP3 Inflammasome Pathway. Toxics 2022;10:285. [DOI: 10.3390/toxics10060285] [Reference Citation Analysis]
2 Vukelic I, Buljevic S, Baticic L, Barisic K, Franovic B, Detel D. CD26 Deficiency Controls Macrophage Polarization Markers and Signal Transducers during Colitis Development and Resolution. IJMS 2022;23:5506. [DOI: 10.3390/ijms23105506] [Reference Citation Analysis]
3 St-Laurent T, Hammami R. The Untapped Potential of Ginsenosides and American Ginseng Berry in Promoting Mental Health via the Gut-Brain Axis. Nutrients 2022;14:2523. [PMID: 35745252 DOI: 10.3390/nu14122523] [Reference Citation Analysis]
4 Zhang B, Liu K, Yang H, Jin Z, Ding Q, Zhao L. Gut Microbiota: The Potential Key Target of TCM’s Therapeutic Effect of Treating Different Diseases Using the Same Method—UC and T2DM as Examples. Front Cell Infect Microbiol 2022;12:855075. [DOI: 10.3389/fcimb.2022.855075] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Cheng H, Liu J, Zhang D, Wang J, Tan Y, Feng W, Peng C. Ginsenoside Rg1 Alleviates Acute Ulcerative Colitis by Modulating Gut Microbiota and Microbial Tryptophan Metabolism. Front Immunol 2022;13:817600. [PMID: 35655785 DOI: 10.3389/fimmu.2022.817600] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]